Summary
Conclusion
the dossier summarised in one paragraphThe file of RENOTECT contains 2 historical bankruptcy publications, as published in the Belgian State Gazette. The computed 12-month bankruptcy probability is 0.8% (low). The 2024 annual accounts show equity of €226k and a net result of €270k. Equity is shrinking by ~25.3% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2025. Its solvency ranks better than 39% of 11087 sector peers (fiscal year 2024).
Based on the State Gazette, CBE and 7 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Insolvency timeline
2 eventsTrust signals
1 signalAdministrative Flags
Financials
Annual accounts & ratios
Source: NBB · 2024How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 31.7% | 40.9% | |
| Net result | €270k | €11k | |
| Equity | €226k | €34k | |
| Gross operating margin | €495k | €35k | |
| Total assets | €711k | €93k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €493k |
| Net profit | €270k |
| Cash flow | €350k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €711k |
| Equity | €226k |
| Debt | €370k |
| of which ≤ 1y | €129k |
| of which > 1y | €240k |
| Working capital | €-19k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.85 |
| Quick ratio | 0.85 |
| Working capital ratio | -2.7% |
| Solvency | 31.7% |
| Debt / equity | 1.64 |
| Long-term debt ratio | 1.07 |
| Interest coverage | 15.01 |
| Gross margin | - |
| Net margin | - |
| ROA | 38.0% |
| ROE | 119.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €711k |
| Fixed assets | 21/28 | €601k |
| Intangible fixed assets | 21 | €2k |
| Tangible fixed assets | 22/27 | €599k |
| Current assets | 29/58 | €110k |
| Amounts receivable within one year | 40/41 | €65k |
| Cash & bank | 54/58 | €44k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €711k |
| Equity | 10/15 | €226k |
| Contributions / capital | 10/11 | €12k |
| Reserves | 13 | €361k |
| Accumulated profits (losses) | 14 | €-147k |
| Provisions & deferred taxes | 16 | €116k |
| Amounts payable | 17/49 | €370k |
| Amounts payable after one year | 17 | €240k |
| Amounts payable within one year | 42/48 | €129k |
| Trade debts payable within one year | 44 | €78k |
| Income statement | ||
| Gross operating margin | 9900 | €495k |
| Operating result | 9901 | €413k |
| Financial income | 75 | €6k |
| Financial charges | 65 | €33k |
| Result before taxes | 9903 | €386k |
| Net result for the period | 9904 | €270k |
| Result to be appropriated | 9905 | €-78k |
Health barometer
FY 2024 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Directors
Directors & mandates
No directors or mandates are on record for this company in the CBE. Not every legal form publishes directors; if they appear in the Belgian State Gazette later, they show up here automatically.
Insolvency mandates
1 mandate| Role | Name | Tenure | Source |
|---|---|---|---|
| Curator | MARTINE DECHERF KLOOSTERSTRAAT 22,
8820 TORHOUT |
18-12-2023 → present | Belgian State Gazette |
Legal Structure
| NACE primary | Algemene elektrotechnische installatiewerken(43211) |
| Legal form | Private limited company(610) |
| Incorporation | 20-11-2009 |
| Status | Active |
| Postal code | 8480 |
| First BS signal | 27-12-2023 |
| Latest BS signal | 08-03-2024 |
Structure & network
Company structure: linked entities
1 linked entityLocations & real estate
Establishment units
1 locationReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 35006D1479/00E000 | Flanders | 1,799 m² | 1 · 275 m² | 9.6 m · 2 fl. |
| 35006D1477/00R000 | Flanders | 295 m² | 1 · 71 m² | 9.2 m · 2 fl. |
Publications
Lifecycle & Insolvency Signals
2 events from the State GazetteTime machine: BS events + macro context
2021-2026Belgisch Staatsblad · acts
1 acts21-01-2022 Registered office moved from Zedelgem to Aartrijke
- L. Devischstraat 20, 8211 Zedelgem → Zangersbos 8, 8211 Aartrijke
Analysis
Snowflake analysis
financial profile on 5 axesExceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
AI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, ranked by comparable sizeCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameNL | RENOTECT |